Skip to main content

Advertisement

SpringerLink
Log in

VI-RADS scoring system for predicting 1- to 5-year recurrence of bladder cancer

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

The Original Article was published on 06 November 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gontero P, Compérat E, Dominguez Escrig JL et al (2023) EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). Available via https://uroweb.org/guidelines/non-muscle-invasive-and-metastatic-bladder-cancer. Assessed 06/10/2023

  2. Witjes JA, Bruins HM, Carrión A et al (2023) EAU guidelines on muscle-invasive and metastatic bladder cancer. Available via https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer. Assessed 06/10/2023

  3. Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 74:294–306

    Article  PubMed  PubMed Central  Google Scholar 

  4. Panebianco V (2023) VI-RADS for the diagnosis and management of urinary bladder cancer. Eur Radiol 33:7209–7211

    Article  PubMed  Google Scholar 

  5. Panebianco V, Pecoraro M, Del Giudice F et al (2022) VI-RADS for bladder cancer: current applications and future developments. J Magn Reson Imaging 55:23–36

    Article  PubMed  Google Scholar 

  6. Metwally MI, Zeed NA, Hamed EM et al (2021) The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study. Eur Radiol 31:6949–6961

    Article  PubMed  Google Scholar 

  7. Luo C, Huang B, Wu Y, Chen J, Chen L (2020) Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis. Eur Radiol 30:4606–4614

    Article  PubMed  Google Scholar 

  8. Pecoraro M, Del Giudice F, Magliocca F et al (2022) Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report. Abdom Radiol (NY) 47:763–770

    Article  PubMed  Google Scholar 

  9. Li J, Cao K, Lin H et al (2023) Predicting muscle invasion in bladder cancer by deep learning analysis of MRI: comparison with vesical imaging-reporting and data system. Eur Radiol 33:2699–2709

    Article  PubMed  Google Scholar 

  10. Xu X, Huang Y, Liu Y et al (2023) Multiparametric MRIbased VI-RADS: can it predict 1- to 5-year recurrence of bladder cancer?. Eur Radiol. https://doi.org/10.1007/s00330-023-10387-8

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

  1. Department of Clinical Radiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110, Ioannina, Greece

    Athina C. Tsili

Authors
  1. Athina C. Tsili
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Athina C. Tsili.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Athina C. Tsili.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was not required.

Ethical approval

Institutional Review Board approval was not required.

Study subjects or cohorts overlap

Not applicable.

Methodology

• commentary

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s00330-023-10387-8.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsili, A.C. VI-RADS scoring system for predicting 1- to 5-year recurrence of bladder cancer. Eur Radiol 34, 3032–3033 (2024). https://doi.org/10.1007/s00330-023-10458-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-10458-w

Search

Navigation